Remicade and Abdominal abscess - a phase IV clinical study of FDA data
Summary:
Abdominal abscess is found among people who take Remicade, especially for people who are female, 10-19 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Remicade and have Abdominal abscess. It is created by eHealthMe based on reports of 201,081 people who have side effects when taking Remicade from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
201,081 people reported to have side effects when taking Remicade.
Among them, 254 people (0.13%) have Abdominal abscess.
What is Remicade?
Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 202,410 Remicade users for its effectiveness, alternative drugs and more.
What is Abdominal abscess?
Abdominal abscess (collection of pus in abdomen) is found to be associated with 1,453 drugs and 901 conditions by eHealthMe.
Number of Remicade and Abdominal abscess reports submitted per year:
Time on Remicade when people have Abdominal abscess *:
Gender of people who have Abdominal abscess when taking Remicade*:
Age of people who have Abdominal abscess when taking Remicade *:
Common drugs people take besides Remicade *:
Common side effects people have besides Abdominal abscess *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Remicade and have Abdominal abscess?
Check whether Abdominal abscess is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Abdominal abscess and when was it recovered:
Expand to all the drugs that have ingredients of infliximab:
Alternative drugs to, pros and cons of Remicade:
- Remicade (202,410 reports)
Common Remicade side effects:
- Drug ineffective: 37,128 reports
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints): 19,890 reports
- Pain: 15,979 reports
- Rashes (redness): 13,566 reports
- Joint pain: 13,157 reports
- Fatigue (feeling of tiredness): 12,449 reports
Browse all side effects of Remicade:
a b c d e f g h i j k l m n o p q r s t u v w x y zAbdominal abscess treatments and more:
- Abdominal abscess (5,154 reports)
COVID vaccines that are related to Abdominal abscess:
- Abdominal abscess in Moderna COVID Vaccine
- Abdominal abscess in Pfizer BioNTech Covid Vaccine
- Abdominal abscess in Johnson and Johnson Covid Vaccine
Common drugs associated with Abdominal abscess:
- Humira: 688 reports
- Prednisone: 550 reports
- Remicade: 254 reports
- Methotrexate: 251 reports
- Accutane: 178 reports
- Prednisolone: 175 reports
- Omeprazole: 153 reports
- Metronidazole: 140 reports
- Metformin: 138 reports
- Azathioprine: 138 reports
All the drugs that are associated with Abdominal abscess:
- Abdominal abscess (1,453 drugs)
Common conditions associated with Abdominal abscess:
- Crohn's disease: 1,251 reports
- Rheumatoid arthritis: 313 reports
- High blood pressure: 184 reports
- Multiple sclerosis: 172 reports
- Pain: 138 reports
- Colon cancer: 108 reports
All the conditions that are associated with Abdominal abscess:
- Abdominal abscess (901 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on infliximab (the active ingredients of Remicade) and Remicade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Clonazepam and Prolixin drug interaction - now
- Theophylline and Vaginal Bleeding Between Periods - 5 seconds ago
- Indomethacin Sodium and Memory Loss - 6 seconds ago
- Clonidine Hydrochloride and Hip Joint Replacement - 23 seconds ago
- Aptiom and Hyponatremia - 33 seconds ago
- Theophyl and Lip Ulceration - 37 seconds ago
- How effective is Azithromycin for Laryngitis? - 41 seconds ago
- Ibrutinib and Bronchospasm Aggravated - 45 seconds ago
- Lamictal and Centella Asiatica drug interaction - 49 seconds ago
- Mixed Hyperlipidaemia and Weakness - 49 seconds ago